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Abstracts. This paper describes clinical cases of HIV-
infection with concomitant cryopathy at different clinical 
stages. The peculiarities of HIV/AIDS according to comor-
bidity and the effect of different modes of treatment on the 
phenomenon of cryoglobulinemia have been characterized. 
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Introduction. Cryoglobulinemia refers to the 
widespread and insufficiently studied phenomena 
that may manifest clinically by the development of 
cold urticaria and angioedema, cryoglobulinemic 
arthrites, vasculites, etc. [5]. Until recently, its 
occurrence associated with a variety of factors and 
diseases: malignant tumors, connective tissue dis-
eases, lymphoproliferative disease, hypothermia, 
dyshormonoses [11]. 
Even with the use of the most modern methods 
of examination about a third of all patients remain 
with cryoglobulinemia in whom the trigger factor of 
cryolabile proteins cannot be established. These 
cases are identified as "idiopathic mixed cryoglobu-
linemia" (IMC) or "essential mixed cryoglobuline-
mia" [9]. In these patients, there are no tumors, sys-
temic connective tissue diseases, lymphoproliferative 
syndromes or active viral infections. As a rule, even 
in the case of repeated examinations, no markers of 
infectious processes are detected. IMC syndrome 
first described by M. Melzer back in 1966 with the 
clinical characteristics, later named Meltzer’s triad: 
skin purpura, arthralgias and weakness. With time, 
the liver, kidneys, nervous system (usually periph-
eral) are involved in the process, relatively rarely 
Raynaud's and Sjogren’s syndromes, diffuse vascu-
litis are detected [9, 13]. 
In some patients the symptoms of IMC may pre-
cede for several years the debut lymphoproliferative 
[15] or autoimmune disease [14], and this period may 
range from 1 to 20 years. Quite often in patients with 
IMC markers or specific histologic manifestations of 
infectious diseases, most often – viral ones, are de-
tected upon a deeper and most detailed examination, 
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ОСОБЕННОСТИ ЛЕЧЕНИЯ БРОНХИАЛЬНОЙ АСТМЫ У ДЕТЕЙ ШКОЛЬНОГО  
ВОЗРАСТА С РАЗНЫМИ ГРУППАМИ КРОВИ 
Л.В. Микалюк, Е.К. Колоскова, С.И. Тарнавская 
Резюме. Проведение комплексного обследования 56 детей, больных бронхиальной астмой, показало, что тя-
желое течение астмы и интенсивность использования комбинации “ингаляционные глюкокортикостероиды + β2-
агонисты короткого действия” характерны для больных с А(ІІ), Rh(-),MN эритроцитарными антигенами. У детей с 
В(ІІІ), М, Rh(+) группами крови наиболее эффективным при наличии тяжелого приступа астмы оказался комплекс: 
системные глюкокортикостероиды, β2-агонисты короткого действия (сальбутамол) и эуфиллин. 
Ключевые слова: бронхиальная астма, дети, группы крови. 
SPECIFIC CHARACTERISTICS OF TREATING BRONCHIAL ASTHMA IN SCHOOL  
AGE CHILDREN WITH DIFFERENT BLOOD GROUPS 
L.V. Mykaliuk, O.K. Koloskova, S.I. Tarnavs’ka 
Abstract. The performance of a complex examination of 56 children afflicted with bronchial asthma has shown a 
severer course of asthma and the intensity of using the combination of "inhalation glucocorticosteroids + β2-agonists of a 
short-term action" inherent to persons with A (II), Rh (-), MN erythrocytic antigens. In children with B (III), M, Rh (+) 
blood groups the following complex turned out to be the most effective in the presence of a severe attack of asthma: sys-
temic glucocorticosteroids, β2 - agonists of a short-term action (salbutamol) and aminophylline. 
Key words: children, bronchial asthma, blood groups 
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especially an amplificated morphologic one [9]. How-
ever, even in such cases, IGC has certain peculiarities 
of the course that distinguish it from typical, secon-
dary mixed cryoglobulinemia. Typically, the symp-
toms of the infection process itself are obliterated, 
faintly marked or absent at all. The clinical presenta-
tion of the disease is dominated by organic lesions at 
that caused by vasculitis. The latter is formed as a 
result of the effect on the vascular endothelium of 
cryoprecipitating immune complexes [7, 8]. 
In recent years, a heated debate over the nature 
and origin of mixed cryoglobulinemia, including the 
idiopathic one have flared up. From the point of view 
of researchers, the cause of the latter may be con-
genital or hereditary defects in the synthesis of im-
munoglobulins, deficiency of trace elements, dyshor-
monoses or yet unknown factors nowdays. If all the 
above mentioned factors play a role of a background 
against which mixed cryopathy is formed, the main 
trigger factors, most researchers still believe to be 
microorganisms, first and foremost - viruses [10]. In 
cases of "an idiopathic" process the releaser role is 
apparently played by yet unknown viruses or patho-
gens whose replication at present is so weak, that it 
is not determined by standard methods. 
In HIV-infected patients a development of a 
variety of clinical manifestations and laboratory phe-
nomena is possible that occur in case of systemic in 
systemic rheumatic diseases. The presence of cell-
specific antibodies, heat-labile proteins – cryoglobu-
lins (CGs) (more often – with concomitant hepatitis 
C), increasing concentrations of acid-labile inter-
feron-α is described[12] 
So it is assumed that CGs have an important 
pathogenetic role in the progression of HIV infection 
[13]. They differentiate 3 main types of CGs: mono-
clonal (type 1) complexes of mono-and polyclonal 
(2nd) and polyclonal ones (3rd). The last two types are 
often called mixed. CGs of type-1 are predominantly 
detected in some versions of malignant tumors and 
lymphoproliferative diseases, and most cases of CGs 
of the 2nd and 3rd types (mixed) are explained by the 
influence of viruses – primarily lymphotropic and 
hepatotropic [4]. The frequent causes of the forma-
tion of thermolabile proteins are often believed to be 
the viruses of human immunodeficiency, hepatites 
(especially C), herpes, cytomegalovirus, Epstein-
Barr virus and others. It is believed that the appear-
ance of the body CG is the result of an antigenic 
stimulation by direct or indirect effects of an infec-
tious agent. In addition, these proteins may appear in 
the body at the secondary phase of the immune re-
sponse in response to infecting or to an inflammatory 
process that occur in the body [6]. 
The aim of the study was to investigate the 
specific characteristics of cryopathies of different 
types in different clinical periods of HIV-infection 
and cryoglobulinemia during a course of 
antiretroviral therapy. 
Material and methods. The study involved 
127 patients with HIV infection who were on an 
ambulatory treatment during 2008-2011 in the 
Regional Center for Prevention and Fight against 
AIDS of Chernivtsi. Among these patients there 
were 66 men and 61 women aged from 19 to 44 
years. 
Study results and discussion. We have found 
out that during the Ist clinical stage of HIV-infection 
in almost half of patients cryoglobulins are detected, 
most of which are mono-and polyclonal (the 2nd 
type). 
With the progression of HIV infection the 
cryoprecipitation phenomenon becomes more 
characteristic: we found CGs of type-2 in an absolute 
majority of HIV-infected persons of the II clinical 
stage, and CGs of the 3-type – in almost every third 
patient at clinical stage III CGs of type 2 and 3 were 
found approximately equally frequently in all the 
patients. 
Our data are consistent with bibliographical 
published reports, according to which patients with 
HIV-infection/AIDS have cryoglobulins which 
consist of polyclonal IgM, IgG or IgA (IgM pos-
sesses the rheumatoid factor activity) [2]. Such a 
composition of cold IgGs is typical of 
cryoglobulinemia of the 2nd and 3d type [3]. 
Cryoglobulinemia syndrome characterized by 
symptomatology polymorphism, has much in common 
with the clinical manifestations of HIV-infection. In 
particular, it concerns a prolonged subfebrile 
temperature, meteorological dependence, poor per-
ception of cold, myalgias and arthralgias, lymph-
adenopathies, vegetative-vascular crises and others [1]. 
So we noticed that patients with HIV-infection 
with cryoglobulins in the blood developed more 
frequently acrocyanosis, poor perception of cold, 
lymphadenopathy and myalgias, i.e., the symptoms that 
are common manifestations of cryoglobulinemia. 
It is logical to assume that cryopathies can 
influence on the course of HIV-infection first and 
foremost, due to the ability of CGs reversibly or 
irreversibly bind virions. Thus, cryoprecipitates of 
type 2, because of their stability, in the peripheral 
vessels do not dissolve in case of a subsequent rise of 
temperature. They partially bind HIV, and bringing it 
to the "periphery", probably, slightly reduce its 
replicative activity. At the IVth clinical stage of HIV-
infection, apparently, with the onset of a 
decompensation of many organs and body systems 
the frequency of the registration of CG decreases 
almost by half. Thus, one can recognize an adaptive, 
protective reaction, at the bases of CG of type 2, 
attempts to "withdraw" the virus from replication 
sites and block it in practically insoluble 
cryoprecipitates. 
In view of this one can explain a fact revealed 
by us of significantly rarer detection of 
cryoglobulinemic cryopathy (only in isolated 
patients) at the stage of wasting syndrome due to 
HIV-infection (the IVth clinical stage). We assume 
that at the terminal stage of HIV-infection due to the 
development of systemic decompensation of organs 
and systems, cryoglobulinemia loses its adaptive 
mechanism. 
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It is likely that the same phenomenon explains a 
direct correlation of the mean force established by us 
(r=0,58) between the level of CD4 +-lymphocytes in 
the range of "500 – 200 in 1 mm3 of blood" and the 
frequency of detecting CG and average force inverse 
correlation (r=-0,53) between the level of CD4 +-
lymphocytes <200 in 1 mm3 of blood" and the 
frequency of detecting CG. 
So cryoglobulinemia is a frequent complication 
of HIV infection that must be considered in the 
algorithm of treatment of such patients. 
It has been found out that as a result of a 3-
month course of HAART, the number of patients 
with CG decreased from 96 (75,6±3,8 %) to 63 
(49,6±4,4 %) patients (p<0,001). Thus, with 
concomitant cryoglobulinemia of type-2, the 
standard first-line HAART not only increases the 
level of CD4 +-lymphocytes and, obviously, reduces 
the replication of the virus, but also eliminates 
cryoglobulinemia in a half of the cured patients (59 – 
46,5±4,4 % to 30 – 23,6±3,8 %) (p<0,001). A 
combination of standard first-line HAART with an 
additional use of antiplatelet agent-dipiridamol 
allows to slightly decrease the percentage of patients 
with the phenomenon of cryoprecipitation. 
However, in AIDS patients with cryoglobulin-
emia of the 3rd type the use of antiretroviral drugs 
(zidovudine + lamivudine + Efavirenz) and 
dipiridamol was less effective (before the start of 
treatment CG was in 33 persons – 26,0±3,9 %, and 
after 3 months of treatment – in 31 patients – 
24,4±3,8 %) (p>0,05) and is accompanied with a 
frequent apposition of AIDS-associated infections. 
We present the findings of our clinical observa-
tions. Patient S., 34 years old, sought a medical advice 
at the Chernivtsi Regional Center for Prevention and 
Control of AIDS, complaining of general weakness, 
drowsiness, fatigue, weight loss by 4 kg per month, 
fever up to 37,5ºC, liquid stools more than 2 times per 
diem for two months, loss of memory, cooling and 
numbing extremities. She had to spend in bed up to 
50 % of the daytime because of weakness. 
From the past medical history it is known that 
the diagnosis of HIV infection confirmed in 2005 
simultaneously with ex-husband patient – an active 
intravenous drug abuser. 
On a physical examination: the nutritional state 
is diminished, shadows under the eyes, the skin is 
pale, dry – seborrheic dermatitis, T – 37,5ºC, cold 
urticaria on both hands. Candidiasis of the mucous 
membranes of the mouth (thrush) onychomycosis of 
the feet. The submandibular, cervical, occipital 
lymph nodes are enlarged, tender on palpation, 
dense. The cardiovascular system: P - 80/min, muf-
fled heart sounds. BP – 110/70 mm Hg. Auscultation 
of the lungs – vesicular breathing, no rales. The ab-
domen is tympanic, diffuse moderate tenderness on 
palpation. No hepatosplenomegaly. Fluid excre-
ments, 2-4 times per diem during last 2 months. 
Clinical diagnosis – HIV, III clinical stage. Clinical 
blood count: erythrocytes – 3,85×1012 /L-1, hem. – 
118 g/l, CI – 1.0; Leuk. – 3,9×109 L-1, eos. – 2 %,  
b. – 8 %, s. – 65 %, lymph. – 17 %, mono. – 8 %, 
ESR – 19 mm/h. Immunological studies: lympho-
cytes – 0,30×109 L-1: 0 lymphocytes – 44,9 %,  
T total – 39,3 %, incomplete T – 19,5 %, T "active" 
– 12,2 %, helpers – 23,4 % suppressors – 13,4 %, D-
cells – 0,8 %, B cells – 4,2 %, IgA – 0,66 g/l, IgM – 
3,5 g/l, IgG – 4,9 g/l, CIC – 126 units., lysozyme – 
2,3 mg/l. The number of CD4+-lymphocytes meas-
ured by flow cytometry made up 260 cells in 1 mm3 
of blood. 
On a coagulogram investigation: a prolongation 
of the prothrombin time, recalcification time. CG of 
type 2 was diagnosed. 
The patient was prescribed first-line antiretrovi-
ral drugs. In 3 months of this therapy her general 
condition essentially improved, the appetite restored, 
she put 3 kg on weight. But she keeps on complain-
ing of rapid fatigability, cooling and numbing of 
limbs, dizziness, and cold urticaria. 
On a physical examination: lymphadenopathy 
retains, but the body temperature during a 24-hours 
period does not rise above 36,9º C. Pulse – 72/min, 
muffled heart sounds. BP is 120/70 mm Hg. Auscul-
tation of the lungs – vesicular breathing, no rales. 
The abdomen is soft, not tender; the liver and spleen 
are not enlarged on percussion and palpation. CG of 
type 2 are continue to be detected. She is receiving 
previous treatment. 
Patient P., 29 years old, appealed for medical 
advice to the Regional Center for the Prevention and 
Control of AIDS, complaining of a significant gen-
eral weakness, rapid fatigue, progressive haggard-
ness, poor appetite, intermittent diarrhea, hands go-
ing blue on their least cooling, cooling and numbing 
limbs, apathy. 
From the past medical history we learn that the 
diagnosis of HIV-infection was confirmed in 1999. 
He was an active intravenous drug abuser. 
On an objective examination: diminished well-
nourished condition, sunken eyes, blue shadows un-
der the eyes, acrocyanosis, extensive onycho-
mycosis. The skin of the hands is cyanotic, cutis 
marmonata on both thighs and legs. The body tem-
perature – 36,6 ºC. The submandibular, cervical, 
occipital lymph nodes are enlarged, tender on 
palpation, dense. The cardiovascular system: P – 80/
min, muffled heart sounds. BP – 110/70 mm Hg. 
Auscultation of the lungs – vesicular breathing, no 
rales. The abdomen is soft, tender on palpation. The 
liver on palpation bulges out at a distance of 2 cm 
from under the edge of the costal margin, tender. The 
splin is not palpated. The excrements are fluid, 4-5 
times per diem during 3 months. Clinical diagnosis – 
HIV, III clinical stage. 
CBC: erythrocytes – 3,6×1012 /L-1, hem. –  
92 g/l, CI – 0.8; leuk. – 4,8×109 L – 1, eos. – 1 %,  
b. – 3 %, s. – 70 %, lymph. – 15 %, mono. – 11 %, 
ESR – 8 mm/h. Biochemistry: bilirubin 23 – µmol/L, 
ALT – 0,84 mmol/(L×h), AST – 0,78 mmol/(l×h). 
Immunological investigation: lymphocytes – 
0,27×109 L-1: 0 lymphocytes – 46,4 %, T total – 
40,2 %, incomplete T – 19,8 % T "active" – 12,6 %, 
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helpers – 22,8 %, suppressors – 12,9 %, D-cells – 
0,8 %, B cells – 4,3 %, IgA – 0,60 g/l, IgM – 3,2 g/l, 
IgG – 4,3 g/l, CIC – 115 units., lysozyme – 2,9 mg/l. 
The number of CD4+-lymphocytes, measured by flow 
cytometry, made up 240 cells in 1 mm3 of blood. 
On a coagulogram examination: a considerable 
prolongation of the prothrombin time and recalcifica-
tion time. CG of type 2 was diagnosed. 
The patient was administered first-line 
antiretroviral drugs and dipiridamol 75 mg in a sin-
gle dose at night once every 2 circadian periods for 3 
months. In 3 months of such therapy his condition 
significantly improved: his appetite restored, cold 
urticaria disappeared, numbness of the extremities 
did not trouble, diarrhea almost calmed down. As a 
result of improved appetite and a normalization of 
evacuation the body weight increased by 3 kg. 
The objective status is indicative of a normal 
body weight, the preservation of general lymphade-
nopathy, the disappearance of acrocyanosis, cold 
urticaria. The pulse – 74/min. The cardiac sounds are 
muffled heart tones. The arterial pressure is 110/70 
mm Hg. On auscultation of the lungs – vesicular 
respiration, no rales. The abdomen is soft, not tender. 
The inferior border of the liver is palpated 1 cm be-
low the costal margin, elastic and not tender. The 
spleen is not palpated.  
CBC: erythrocytes – 4,0×1012 /L-1, hem. –  
105 g/l, CI – 0,9; leuk. – 5,5×109 L-1, eos. – 0 %,  
b. – 6 %, s. – 56 %, lymph. – 21 %, mono. – 17 %, 
ESR – 11 mm/h. The biochemical blood analysis did 
not practically change: bilirubin 21 – µmol/L, ALT – 
0,78 mmol/(l×h), AST – 0,75 mmol/(l×h). 
Immunological studies are indicative of an increase 
of the number of lymphocytes – up to 0,81×109 L-1: 
0 lymphocytes – 28,2 %, T total – 45,6 %, 
incomplete T – 18,0 %, T "active" – 18,4 %, helpers 
– 24,7 %, suppressors – 12,5 %, D-cells – 2,2 %, B 
cells – 7,3 %, IgA – 0,76 g/l, IgM – 3,4 g/l, IgG – 4,2 
g/l, CIC – 100 units, lysozyme – 3,2 mg/l. The num-
ber of CD4 +-lymphocytes, measured by flow 
cytometry, increased to 410 cells in 1 mm3 of blood. 
Conclusions 
It is known that type 3 cryoprecipitates are more 
heat-labile, compared with type 2. In an insoluble 
form, they are not able to consistently block virions, 
but only protect them from the effects of the immune 
system and etiotropic medications. In case of a rise 
of temperature type 3 cryoprecipitates partially dis-
solve. A significant part of virions released, at that 
and undessolved components of a cryoprecipitate 
flow back into the systemic circulation and block the 
blood vessels of the microcirculation, causing stable 
rheological and microcirculatory disorders, thereby, 
obviously, provoking the development of vasculites, 
Raynaud's syndrome or arthropathies. 
Thus, the phenomenon of cryoglobulinemia, 
which is the result of the HIV action, has an opposite 
effect on the course of viral infection and determines 
its characteristics. 
Thus, a significant impact on the course of 
HIV-infection is, to a considerable extent, exerted by 
concomitant cryoglobulinemia that must be consid-
ered, when diagnosing illnesses and treating such 
patients. In particular, a combination of standard 
HAART based on the first line regimen (zidovudine 
+ lamivudine + Efavirenz) with an additional use of 
the antiplatelet agent-dipiridamol makes it possible 
to lower somewhat the percentage of patients with 
the phenomenon of cryoprecipitation. 
Prospects for further research. To study the 
role of the endothelium in the pathogenesis of HIV-
infection. 
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КЛИНИЧЕСКАЯ ХАРАКТЕРИСТИКА ТЕЧЕНИЯ ВИЧ-ИНФЕКЦИИ  
С СОПУТСТВУЮЩЕЙ КРИОГЛОБУЛИНЕМИЕЙ 
В.Д. Москалюк, В.Д. Сорохан, С.Р. Меленко, И.В. Баланюк, К.И. Возна 
Резюме. В статье описаны клинические случаи ВИЧ-инфекции с сопутствующей криопатией в различных 
клинических стадиях. Охарактеризованы особенности течения ВИЧ/СПИДа в зависимости от сопутствующей пато-
логии и влияния различных методов лечения на феномен криоглобулинемии. 
Ключевые слова: ВИЧ-инфекция/СПИД, криопатия, криоглобулины, антиретровирусная терапия, дипиридамол. 
КЛІНІЧНА ХАРАКТЕРИСТИКА ПЕРЕБІГУ ВІЛ-ІНФЕКЦІЇ ІЗ  
СУПУТНЬОЮ КРІОГЛОБУЛІНЕМІЄЮ 
В.Д. Москалюк, В.Д. Сорохан, С.Р. Меленко, І.В. Баланюк, Х.І. Возна 
Резюме. У статті описано клінічні випадки ВІЛ-інфекції із супутньою кріопатією у різних клінічних стадіях. 
Охарактеризовано особливості перебігу ВІЛ/СНІДу залежно від супутньої патології та впливу різних методів ліку-
вання на феномен кріоглобулінемії. 
Ключові слова: ВІЛ-інфекція/СНІД, кріопатія, кріоглобуліни, антиретровірусна терапія, дипіридамол. 
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Abstract. On the basis of inspection 127 patients with 
HIV-infection/AIDS it has been established that in case of 
this pathology the concentration of thrombomodulin, Е-
selectin and von Willebrand’s factor substantially grows, 
which is indicative of a HIV-induced affection of the vas-
cular wall. As immunodeficiency progresses, the concentra-
tion of all the mentioned indices grows significantly. 
3-month symptomatic therapy does not influence on 
the state of the endothelium. The use of the dipiridamol, 
aggregant, and also a 3-month antiretroviral treatment of 
the first row provide only a partial decline of the thrombo-
modulin, Е-selectin and von Willebrand’s factor levels.  
However, the inclusion to the antiretroviral therapy 
(ART) of dipiridamol maximally optimizes the endothelial 
state of the endothelium: the level of thrombomodulin and 
von Willebrand’s factor at the IInd clinical stage of HIV-
infection normalizes and at the IIId-IVth stages – signifi-
cantly lowers, although it does not reach the values of 
healthy persons. The same ponderable difference is estab-
lished in relation to the content of Е-selectin. 
Key words: HIV/AIDS, endothelial dysfunction, 
treatment. 
Introduction. Special attention of scientists has 
been focused on the role of the endothelium in the 
pathogenesis of HIV infection lately. Locally, the 
endothelium forms the wall of the hepatic hemocapil-
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